Skip to content

Clinical trials

Metabolism, Inborn Errors trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolism, Inborn Errors Country / region: India Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20171
20181
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CENTOGENE GmbH Rostock2
Regeneron Pharmaceuticals2
JCR Pharmaceuticals Co., Ltd.1
Sumitomo Pharma Switzerland GmbH1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolism, Inborn Errors6
Genetic Diseases, Inborn5
Lysosomal Storage Diseases3
Metabolic Diseases3
Musculoskeletal Diseases3
Arthritis2
Brain Diseases, Metabolic, Inborn2
Gout2
Joint Diseases2
Purine-Pyrimidine Metabolism, Inborn Errors2

Trials

Showing 76 to 6 of 6. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.